Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
JAMA Neurology
Published October 22, 2026
Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis.
October 24, 2026
Medspoke
Medspoke
Neurology
Published October 22, 2026
00:00
--:--
Antidopaminergic Medications and Clinical Outcomes in Huntington Disease: Evidence From the PROOF...
October 24, 2026
Share
Antidopaminergic Medications and Clinical Outcomes in Huntington Disease: Evidence From the PROOF-HD Placebo-Controlled Trial.
https://www.medspoke.co/channel_journal?id=792&tap_id=16244
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Neurology
Published October 23, 2026
Blood-Based Biomarkers as Predictors of All-Cause Dementia: A 13-Year Follow-Up in the Whitehall ...
October 24, 2026
Why are you reporting this TALK?
